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Abstract 
Immunoglobulin E high affinity receptor-mediated signal transduction in mast cells results in a number of protein tyrosine kinases 
being activated as very early events in the process leading to degranulation. Some of these, such as the src kinases and the syk kinase, 
are known to be involved in this receptor-associated activation. In this paper we describe the search for other activation-associated 
tyrosine kinases by the ability to phosphorylate a cytoplasmic domain peptide of the Fc,RI y-subunit. In utilizing a purification step 
previously used to isolate the 72 kDa syk kinase, we detected another kinase of molecular weight 79 kDa which we designated cdy 
kinase. The kinase was purified to near homogeneity by Heparin-agarose, Mono Q, and CM Sepharose chromatographies. The yield of 
enzyme was approx. 200 pg,‘109 cells. We characterized this kinase by its ability to phosphorylate both the cdy peptide (K, = 0.2 mM) 
and the cytoplasmic fragment of the Band III protein. The cd-y kinase was distinguished from syk by inability to be precipitated by 
anti-& antiserum and by partial peptide mapping. Cd-y kinase was also distinguished from syk by cdy peptide and Band III substrate 
specificity. We identified the cdy kinase by Western blotting and by partial phosphopeptide mapping as Btk, the B-cell tyrosine kinase 
found to be defective in X-linked agammaglobulinemia. 
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1. Introduction 
In the antigen-mediated stimulation of mast cells and 
basophils it is well established that tyrosine phosphoryla- 
tion of p and y subunits of the Fc,RI receptor plays a 
major role in cellular signaling. The rat basophilic leukemia 
(RBL-2H3) cell line is frequently used as a model for 
Fc,RI receptor signaling. It has been shown clearly by 
Kinet et al. that tyrosine phosphorylation of Fc,RI /3 and 
y subunits is closely linked with early events in receptor 
signaling [1,2]. A number of protein tyrosine kinases 
Abbreviations: Fc,RI, high affinity receptor for Immunogobulin E; 
PTK, protein tyrosine kinase; IMP, dinitrophenol; BSA, bovine serum 
albumin; RBL, rat basophilic leukemia 2H3 cell line; SDS-PAGE, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; TIU, trypsin inhibitor 
units; GST, glutathione S-transferase; ECL, enhanced chemilumines- 
cence; HRP, horseradish peroxidase; SH, Src homology region; PCR, 
polymerase chain reaction. 
* Corresponding author. 
(PTK’s) have been implicated in the phosphorylation of 
Fc,RI. The src family kinases, lyn and src have been 
shown to be activated in antigen-stimulated RBL cells [3]. 
The src kinase yes has been shown to be activated in the 
mouse mast cell line PT-18 [4]. Also, a non-src-like kinase 
of molecular weight 72 kDa has been identified which was 
shown to be identical to the B-cell kinase PTK 72 [S]. 
When protein sequence of the B-cell 72 kDa protein was 
used for cloning cDNA, a gene was identified, designated 
syk, which codes for a protein having 2 N-terminal SH-2 
domains and a C-terminal tyrosine kinase domain [6]. 
Recent evidence suggests that there is a substantial 
amount of tyrosine-phosphorylated protein in the region of 
72 kDa which is not the syk gene product [7]. In addition 
to tyrosine phosphorylation of Fc,RI, other downstream 
elements such as phospholipase C-y [S] and the MAP 
kinases [9] have been shown to be activated by tyrosine 
phosphorylation in mast cells. In light of this, we sought to 
identify other PTK’s that might be involved in Fc,RI 
signal transduction. Using an Fc,RI y-cytoplasmic domain 
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peptide as substrate, we identified a tyrosine kinase having 
a molecular weight of 79 kDa. Several reports have been 
published on PTK’s at this molecular weight range. 
Tsukada et al. [lo] have recently described the primary 
amino acid sequence of a 77 kDa tyrosine kinase, which 
they termed BPK, derived from cDNA sequencing in 
human and murine B-cells. These investigators also showed 
that there were reduced mRNA and protein levels of BPK 
in Epstein-Barr virus-transformed B-cells from X-linked 
agammaglobulinemia (XLA) patients. Chromosomal local- 
ization of the bpk gene at DXS178 was tightly linked with 
the XLA polymorphism. This indicated that a defect in the 
bpk gene and lack of the BPK protein were responsible for 
the agammaglobulinemia. This finding was confirmed by 
Vetrie et al. [ll]. In a murine system, Thomas et al. [12] 
and Rawlings et al. [13] have characterized a similar 
X-linked agammaglobulinemia (xid) resulting from substi- 
tution of a cysteine for an arginine at position 28 of this 
same tyrosine kinase. Both of these groups have adopted 
the term Btk for the murine and human proteins. Yamada 
et al. [14] demonstrated the presence of Btk mRNA in 
murine mast cells (referred to as EMB). Btk mRNA has 
also been detected in the human immature basophilic cell 
line KU812 and the human mast cell line HMC-1 [15]. In 
this paper we also identified the 79 kDa tyrosine kinase we 
have purified from rat basophilic leukemia (RBL) cells (a 
rat mast cell line) as the Btk protein, using anti-Btk 
Western blotting and partial phosphopeptide mapping. 
2. Materials and methods 
2.1. Antibodies 
Monoclonal DNP-specific IgE was purified from HI- 
DNP-e-26.82 hybridoma (cell line was a gift from Dr. 
F.-T. Liu, Scripps Institute, La Jolla, CA) according to Liu 
et al. [16]. DNP,,BSA was synthesized according to Farah 
et al. [17]. Btk anti-peptide antibodies were made in rabbits 
against previously determined mouse Btk sequences [14]. 
For anti-Btk(A), a GST fusion protein containing amino 
acid sequence 24-175 was injected. For anti-Btk(B), the 
C-terminal peptide amino acid sequence 646-660 was 
injected. Antibody to the tyrosine kinase substrate P75, a 
protein phosphorylated in antigen-stimulated mast cells, 
was made in rabbits by injection of peptide amino acid 
sequence 83-96 as previously described 1181. Anti-syk 
antiserum was made in rabbits against the C-terminal 
peptide amino acid sequence 601-628 (a gift of Dr. Robert 
Gaehlen, Purdue University, West Lafayette, IN). Mono- 
clonal antibody raised against murine Fc,RI a subunit 
(ER4.7 cell line) was a gift from Dr. Zelig Eshhar (Dept. 
of Immunology, The Weizmann Inst. of Science, Israel). 
Anti-phosphotyrosine (PY20) horseradish peroxidase con- 
jugated antibody was purchased from ICN (Irvine, CA). 
Affinity pure anti-mouse IgG (from goat) and anti-rabbit 
IgG (from donkey) conjugated to horseradish peroxidase 
were purchased from Amersham (Arlington Heights, IL). 
Non-specific whole rabbit IgG was purchased from Sigma. 
2.2. Cells 
RBL 2H3 cells were cultured in minimal essential 
medium (DMEM, Mediatech) with 15% heat-inactivated 
fetal bovine serum, penicillin/streptomycin, and 1 mM 
glutamine. Cells were sensitized by a l-h preincubation 
with 5 pg/ml monoclonal DNP-specific IgE [16]. Adher- 
ent cells were harvested by preincubation in detachment 
medium (135 mM NaCl/S mM KC1/5.6 mM glucose/l0 
mM Hepes [pH 7.0]/0.7 mM EDTA) and detached by 
hitting the flask on a hard surface. After washing the cells 
in minimal essential medium plus serum, cells were re-sus- 
pended in Tyrode’s solution (135 mM NaCl/S mM 
KC1/1.8 mM CaCl,/l mM MgC1,/5.6 mM glucose/l0 
mM Hepes [pH 7.4]/0.1% BSA). Cells (1 X 108/ml) 
were then stimulated by addition of 100 nM DNP,,BSA 
for 90 s. Alternatively, cells were triggered without sensi- 
tizing with IgE, but by addition of 20 pg/ml anti-a 
monoclonal antibody ER4.7 for 90 s. 
2.3. Purification of cdy kinase 
IgE-sensitized RBL cells (1.2 X 109) were stimulated 
by DNP,,BSA and then lysed in Extraction Buffer (10 
mM Hepes [pH 7.4]/1% digitonin/ 0.25 M sucrose/l 
mM EDTA/l mM EGTA/l mM orthovanadate/3 PM 
Leupeptin/3 /IM Pepstatin/O.lS TIU/ml Aprotinin/and 
0.25 mM phenyl methyl sulfonyl fluoride (PMSF)) at a 
final concentration of 2.4 X lo7 cells/ml. Cell extracts 
were centrifuged at 27k x g in a Sorvall SS-34 rotor at 
4°C. The supematant was then applied to a 1 X 5 cm 
column of Heparin-agarose (Sigma). The column was 
washed with 3 column volumes of 20 mM Hepes [pH 
7.4]/0.1% Triton X-100/1 mM orthovanadate/l mM 
EDTA/l mM EGTA (Buffer A), followed by 4 column 
volumes of 0.2 M NaCl plus Buffer A. Kinase activity was 
eluted with 4 column volumes of 0.65 M NaCl plus Buffer 
A. The eluted material, typically a volume of 20 ml, was 
dialyzed twice vs. 1.5 liters of Buffer A and then applied 
to a Mono Q HR 5/5 column (Pharmacia). Kinase activity 
was assayed by phosphorylation of a human cdy synthetic 
peptide (RLKIQVRKADIASREKSDAVYTGLNTRN- 
QETYETLK) as described below. Elution from the Mono 
Q was performed with a O-O.4 M NaCl gradient (60 ml) in 
Buffer A. Pooled fractions were dialyzed twice vs. 1 liter 
of Buffer A and then applied to a column of 1 X 5 cm CM 
Sepharose Fast Flow (Pharmacia) equilibrated with Buffer 
A. The column was eluted with a 40 ml gradient of O-O.5 
M NaCl in Buffer A. The eluted cd-y kinase activity was 
pooled, dialyzed vs. Buffer A supplemented with glycerol 
to a final concentration of 50% and stored at -20°C. 
Protein concentration was measured by BCA assay (Pierce, 
Rockville, IL) using human IgG as standard and measuring 
absorbance at 595 nm. Protein fractions were also analyzed 
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by reduced SDS-PAGE (10% or 16% acrylamide, Tris-Tri- 
tine, NOVEX, San Diego, CA). Molecular weight stan- 
dards of 14-97 kDa were obtained from BioRad (Rich- 
mond, CA), and standards of 2.3-43 kDa were obtained 
from Gibco/BRL (Bethesda, MD). 
2.4. Assay of cdy kinase ,activity 
Fractions were incubated with final concentrations of 50 
mM Hepes [pH 7.4]/10 mM MnClJO.1 mM orthovana- 
date/100 PM y3’ P ATP (approx. 2000 cpm/pmol) in the 
presence or absence of 10 PM cdy peptide. After 10 min 
at 3O”C, reactions were stopped by application to P81 filter 
squares (Whatman), immersed in 75 mM H,PO,, washed 
4 X 5 min in the same buffer, rinsed in acetone and 
counted by scintillation. For some assays, the cytoplasmic 
fragment of erythrocyte Band III [19] was used as a 
substrate (a gift from Dr. Robert Geahlen, Purdue Univer- 
sity, West Lafayette, IN). In some cases, assays were 
stopped by addition of SDS containing buffer and samples 
were applied to SDS-PAGE (reduced). 
2.5. Immunoprecipitations and Western blots 
RBL cells stimulated as above were lysed in Extraction 
Buffer (above). Extracts were centrifuged 27k X g 20 min 
at 4°C. Supernatants from stimulated or non-stimulated 
cells were pre-absorbed with Sepharose beads (0.5 h rock- 
ing, 25 ~1 beads/ml extract), then precipitated for 1.5 h 
with antibody as indicated in the legend along with Protein 
G Sepharose (20 ~1 beads/l ml extract, Pierce, Rockville, 
IL). Precipitates were washed thrice with 1 ml Extraction 
Buffer followed by one wash of Buffer A. All these steps 
were conducted at 4°C. Precipitates were then subjected to 
an in vitro kinase assay as described above followed by 
SDS-PAGE, transfer to Ilmmobilon P (Millipore, Bedford, 
MA) and 1 M KOH incubation at 60°C for 1 h to select for 
phosphotyrosine-containing proteins [20]. For Western 
blotting, extracts as above were run on SDS-PAGE and 
transferred to nitrocellulose. Standards were visualized by 
Ponceau S (Sigma) and the transfers were then blocked for 
1 h with 4% BSA in 10 mM Tris-HCl, pH 7.4/150 mM 
NaCl/l% Tween 20 (TBST). The membranes were incu- 
bated with primary antibodies (1 to 5 pg/ml in 4% BSA 
plus TBST) followed by anti-mouse-HRP (l/5000 dilu- 
tion in TBST) and developed by chemiluminescence (ECL, 
Amersham, Arlington Heights, IL). 
2.6. Partial peptide mapping 
Purified cdy kinase and immunoprecipitated syk were 
autophosphorylated in vitro as above and run on 10% 
SDS-PAGE. PhosphoryLated bands were cut from the 
stained, fixed gel and subjected to partial peptide mapping 
by the method of Cleveland et al. [21] using V8 proteinase 
(Boehringer Mannheim). 
Table 1 
Purification of cdy kinase from RBL ceils. Cd-y Kinase activity from lo9 
RBL cells was purified as described in Section 2. Assay of enzyme 
activity was carried out by phosphorylation of cdy peptide and quantita- 
tion on P81 filter squares. One unit of activity represents 1 pmol/min 
32 Pi incorporated into cd-y peptide 
Fraction Activity 
(Units) 
Protein 
(mg) 
Spec. Act. 
(Units/mg) 
Crude extract 
Heparin-agarose 
Mono Q HR 5/5 
CMSephadex 
_ 429 
3438 295 11.7 
253.9 26 9.8 
119.8 0.195 614 
2.7, Phosphoamino acid analysis 
32P phosphorylated protein bands were eluted from 
non-fixed SDS-PAGE gels by incubation of the crushed 
gel in 0.5% SDS for 12 h at 37”C, desalted by chloro- 
form/methanol precipitation and then hydrolyzed by 6 M 
HCl for 1 h. Samples were extensively lyophilized and 
separated on cellulose/acetate chromatography [pH 3.51 
with appropriate standards [22]. Standards (phospho- 
threonine, -serine, and -tyrosine (Sigma)) were stained by 
ninhydrin and phosphorylations were visualized by auto- 
radiography. 
3. Results 
3.1. Purification of a cdy kinase 
In our search for tyrosine kinases involved in Fc,RI- 
mediated signal transduction, we first examined a phospho- 
Antigen + - 
I 1 
Fig. 1. Anti-phosphotyrosine blotting of RBL extracts. Adherent RBL 
cells were sensitized with DNP-specific IgE at 5 pg/ml, then detached 
and stimulated (+ /-) with final 20 mg/ml of DNP,,BSA. High speed 
supematants of Triton X-100 extracts were subjected to Western blotting 
with PY20-HRP antibody as described in Section 2. 
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tyrosine blot of crude extracts from antigen-stimulated tion which are likely to be the p subunit (approx. 31 kDa) 
cells vs. non-stimulated cells (Fig. 1). Consistent with and y2 subunit of the Fc,RI receptor (approx. 22 kDa). 
previous reports [1,8,23], two bands appear after stimula- Two additional strong bands appear at about 70 kDa and 
20 30 
Fraction 
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Fig. 2. A: Chromatography of cdy kinase on Mono Q. The dialyzed high salt eluate from Heparin-agarose elution (approx. 30 ml) was applied to Mono Q 
HR 5/5 as described in Section 2. Fractions were assayed for cdy kinase activity (0) and protein (0). The solid diagonal line represents a 75-ml linear 
gradient of O-O.4 M NaCl in Buffer A. The horizontal bars under the peaks of activity represent fractions pooled for further purification (both 2A,2B). B: 
Chromatography of cd-y kinase on CM Sepharose. The dialyzed pool of Mono Q (10 ml), was applied to CM Sephadex Fast Flow. As above, fractions 
were assayed for cdy kinase activity (0) and protein (0). Solid diagonal line represents a linear gradient of 0.025-0.50 M NaCI. C: Analysis of purified 
cd-y kinase by SDS PAGE and phosphoamino acid analysis. Left panel: 5 pg purified cdy kinase was 32P autophosphorylated and run on 10% SDS 
PAGE with appropriate standards, showing autoradiography (P-32) and Coomassie stain (prot). Middle panel: purified cdy kinase was incubated with 
[ y3’P]ATP in the presence or absence of cdy peptide substrate and run on 16% SDS-PAGE. Left margin indicates Gibco/BRL standards. Right margin 
indicates Bio-Rad standards. Right panel: bands from autophosphorylation and cdy substrate phosphorylation were subjected to phosphoamino acid 
analysis with indicated standards: PY, phosphotyrosine; PS, phosphoserine; PT, phosphothreonine. 
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60 kDa. There are also a large number of stimulated approx. 75 kDa, which may be a degradation of the 79 
tyrosine phosphorylated blands in the range of approx. 45 kDa species. Also shown is a demonstration of substrate 
kDa to 200 kDa. This complexity indicates the likelihood phosphorylation of cd-y (4.9 kDa) and the associated auto- 
of a number of different kinases being involved in the cell phosphorylation (79 kDa). When these bands were ex- 
activation resulting from Fc,RI cross-linking. We first cised, eluted and subjected to phosphoamino acid analysis, 
searched for receptor (19,-y) kinases by the ability to both species showed only phosphotyrosine, indicating that 
phosphorylate the human y cytoplasmic domain peptide the enzyme is a tyrosine kinase (Fig. 2C). Fig. 3 shows 
(cdy). Because this peptide appeared to be fairly non- SDS-PAGE analysis of the CM Sepharose eluted peak 
specific serving as a substrate for serine, threonine, and fractions of cdy activity. The 79 kDa protein (Coomassie 
tyrosine kinases, we were not able to use it for assaying brilliant blue-stained), 32 P autophosphorylated 79 kDa 
the crude extracts. A preliminary attempt to isolate the band, and 4.9 kDa 32P phosphorylated cd y substrate when 
PTK 72 kinase from stimulated RBL cells utilizing Hep- quantitated (lower panel), indicated the presence of a 
arin-agarose chromatography [5] resulted in isolation of single autophosphorylating tyrosine kinase at fractions 38- 
cdy phosphorylating activity. However, when Heparin- 42 of the CM Sepharose column, coincident with activity 
agarose eluates were observed by PY20 phosphotyrosine phosphorylating the cdy peptide. Table 1 summarizes the 
blotting (data not shown), instead of the expected 72 kDa purification of cdy kinase from antigen-stimulated RBL 
band, a 79 kDa band was observed which appears not to be cells. The fact that almost 200 pg of enzyme was purified 
the syk gene product (see below). Subsequent purification from 429 mg (1 X lo9 cell equivalents) of starting material 
by Mono Q and CM Sepharose chromatographies (Fig. indicates that this tyrosine kinase is present at relatively 
2A,B) resulted in purification of a 79 kDa polypeptide high levels. We have designated this enzyme cdy kinase 
with associated cd-y kinase activity. Fig. 2C shows SDS- since this was the activity sought in the outset of this 
PAGE of the purified enzyme (autophosphorylated [P-32] study. Fig. 4 indicates the substrate dependence of cdy 
and Coomassie brilliant blue-stained [prot.]). A minor kinase for the cdy substrate as a Lineweaver-Burk plot 
autophosphorylation band was also occasionally seen at showing a calculated K, of 0.2 mM. 
CM fraction 
A. Protein 79K ---) 
6. Autophos. 79K + 
C. cdy Pept. 4.91( 
37 38 39 40 41 42 43 
600. 
600 . 
-4 
-3 
-2 
-1 
ol . 1 . I . I . 1 . 10 
;JO 34 36 42 46 50 
Fraction 
Fig. 3. Co-elution of cdy kinase activity, 79 kDa autophosphorylation, and 79 kDa protein stain on CM Sepharose chromatography. Upper panel: aliquots 
from CM Sepharose were run directly on 10% SDS PAGE and stained by Coomassie brilliant blue protein stain (A), and in vitro phosphorylated ?P) in 
the presence of 30 PM cd-y peptide and run on 16% SDS PAGE followed by autoradiography (B,C). Lower panel: quantitation of electrophoretic bands: 
79 kDa autophosphorylation (17) by scintillation counting; 79 kDa protein (0) by scanning densitometry; 4.9 kDa phosphorylation band (A) by 
scintillation counting. 
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Fig. 4. Lineweaver-Burk plot for cdy substrate dependence of cdy 
kinase. Cdy kinase (75 pg) was assayed in the presence of increasing 
concentration of cd-y peptide along with 200 PM y3*P ATP/SO mM 
Hepes (pH 7.4)/10 mM MnCI, /O.l mM orthovanadate. Assays were 
otherwise as described in Section 2, and quantitated on P81 squares. 
3.2. Determination of the identity of cdy kinase 
Since the purified cdy kinase had some of the proper- 
ties of the kinase PTK 72”yk- elution from Heparin-Sep- 
harose, and molecular weight in the range of 70-80 kDa, 
we compared the syk kinase and the cdy kinases accord- 
ing to substrate specificity and also antigenically. Syk 
antibody 
ER 4.7 
activation 
A B 
Fig. 5. Comparison of cdy kinase to syk by cross-immunoprecipitation. Panel A: Triton X-100 extracts of RBL cells, with or without prior stimulation by 
anti-a subunit antibody, were subjected to precipitation with anti-syk or non-specific rabbit IgG and then precipitates were 32P phosphorylated in vitro. 
Transfers of SDS PAGE were analyzed by autoradiography for 32P-phosphotyrosine as described in Section 2. Panel B: Anti-syk precipitate of crude 
extract is compared with anti-syk and non-specific rabbit IgG precipitates of the pure cdy kinase treated according to the method used in panel A. 
-yk N.S. 
-+ +- +- 
Table 2 
Substrate reactivity of syk kinase and cd-y kinase. Kinase activities were 
measured by incorporation of 32P into cdy peptide (final 30 PM) or 
Band III (final 2.5 PM). Partially purified syk kinase was derived from 
an anti-syk precipitate of crude RBL extracts and the activity represents 
the difference between stimulated and non-stimulated cell extracts. In all 
cases, kinase reaction mixtures were run on SDS-PAGE and quantitated 
by excising the substrate band and counting by scintillation. Standard 
deviations of trinlicate assays are indicated 
Phosphate incorp. (pmoI/min) Ratio cdy/Band III 
cdy peptide Band III 
syk kinase 0.428 + 0.140 0.256 + 0.029 1.67 
cdy kinase 0.160+0.011 0.052 f 0.015 3.08 
kinase activity was obtained by specifically immunoprecip- 
itating with anti-syk antibody and then conducting an in 
vitro kinase assay on the Protein A Sepharose beads with a 
known substrate. As expected, the anti-syk precipitate 
from antigen-stimulated extracts showed a stimulated 72 
kDa autophosphorylated band (Fig. 5A), and an approx. 
3-fold stimulation of exogenously added Band III phospho- 
rylation (data not shown). We compared the ability of 
either syk or cdy kinase to phosphorylate the substrates 
Band III and cdy peptide (Table 21. Although both en- 
zymes phosphorylated Band III and cdy, the amount of 
cdy peptide phosphorylation was significantly higher for 
cdy kinase compared with the syk kinase (P-value < 
Crude Extr. 1 Gamma kinase 
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0.025) when normalized1 for Band III phosphorylation. 
When we attempted to precipitate the pure cdy kinase 
with anti-syk under the same conditions used for syk 
precipitation (Fig. 5A), Twe were not able to recover an 
autophosphorylating cd y kinase in the anti-syk precipitate 
(Fig. 5B). We also found that partial phosphopeptide maps 
of cdy kinase and syk were very dissimilar. These results 
were a strong indication that the enzyme that we purified 
was not syk. 
Since the pure enzyme was very close in molecular 
weight to a recently cloned tyrosine kinase gene product 
referred to as Btk [lo], we performed Western blotting on 
the purified enzyme using antibodies to various Btk pep- 
tides. As shown in Fig. 6, Western blotting with both 
peptide antibodies anti-Btk(A), specific for an N-terminal 
segment, and anti-Btk(B)l, specific for the C-terminus (see 
Section 2) revealed strong cross-reactivity with the pure 
cdy kinase 79 kDa protein band. With anti-Btk(A) a weak 
band was observed at aplprox. 21 kDa. This is likely to be 
an N-terminal fragment of Btk which is not recognized by 
the C-terminal-specific anti-Btk(B). Two additional anti- 
Btk peptide antibodies directed to the internal sequences 
IHQLKNVIRYNSDLVQbKYHP (residues 125-144) and 
KPGSSHRKTKKPLPPTPEED (residues 176-195) [14] 
also recognized blotted cdy kinase (not shown). These 
data suggest that epitopes on cdy are cross-reactive with 
multiple regions, including the C- and N-terminal ends of 
97 
79K_ 
66 
Btk, largely excluding the possibility of cdy kinase being 
a rearranged gene product containing only a small segment 
of Btk. The Btk protein was also shown to be present in 
crude extracts by the same antibodies. When an unrelated 
antibody to the tyrosine kinase substrate P75 (see Ref. 
[24]) was used to probe identical blots, no reactivity was 
seen against the purified cdy kinase, although we did 
detect P75 in the crude extract. In order to further confirm 
the identification of cdy kinase as Btk, we performed 
partial digest of the two proteins and analysis on SDS- 
PAGE. When 32P- autophosphorylated cdy kinase was 
compared with 32 P-autophosphorylated Btk from RBL cell 
immunoprecipitates, almost identical partial digests were 
produced by exposure to V8 proteinase at two different 
concentrations of V8 (Fig. 7). Minor differences might be 
attributed to the presence of associated proteins in the 
immunoprecipitate and not in the pure cd y kinase or to the 
difference in the amounts of pure and precipitated en- 
zymes. Since all of the above antibodies are anti-peptide 
antibodies, and were raised against peptides with se- 
quences deduced from the nucleotide sequence of the Btk 
gene, we have further confirmed that these antibodies 
indeed recognize the genuine Btk gene product. Lysates 
were prepared from a B-cell line (WEHI-231), from the 
negative cell line NIH/3T3 and from a stable NIH/3T3 
transfectant expressing the Btk gene. Immunoprecipitation 
with anti-Btk(A) (Fig. 8, ‘anti-Emb(A)‘) or normal rabbit 
Anti-Btk(A) Anti-Btk(B) Anti-P7 5 
Fig. 6. Western immunoblottin,g of cd-y kinase with ant-Btk peptide antibodies. Either 25 pg crude RBL extract or 0.56 pg cdy kinase samples were run 
on SDS PAGE and transfers were blotted with anti-Btk(A) (left), anti-Btk(B) (middle), or anti-P75 (right). 
MW 
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20( 
97 
Undigested 
Btk 
68’ 
29 
18 
14 
Fig. 7. Partial V8 digest of P-32 autophosphorylated Btk kinase (immuno- 
precipitated) vs. pure cd-y kinase on SDS PAGE. Lanes 1,3: Btk precipi- 
tated from crude RBL Extract (anti-Btk(A)); Lanes 2,4: pure cdy kinase. 
Digests were at two different concentrations of V8 protease: lanes 1,2: 
0.4 pg/ml; lanes 3,4: 4.0 pg/ml. 
serum, followed by in vitro phosphorylation and PAGE 
analysis clearly demonstrate the ability of this antibody to 
precipitate Btk from genuine expressors like the B-cell line 
and the transfected line, but not from the negative control 
(NIH/3T3) (Fig. 8). The Btk protein from these cells also 
co-migrated with the auto-phosphorylating cdy kinase (Fig. 
8, right lane). Furthermore, the phosphopeptide maps of 
the three Btk gene products shown in Fig. 9, all show 
identical peptide maps as those found in the mast cell 
lysates. The high specificity of the antibodies used in this 
study for Btk, together with the phosphopeptide mapping 
data form RBL cells and from genuine Btk gene express- 
ing cells, clearly indicated that the cdy kinase which we 
purified is in fact the cloned Btk gene product. 
4. Discussion 
In this paper we describe the search for tyrosine kinases 
in mast cells based on the ability to phosphorylate an 
Fc,RI gamma-cytoplasmic domain peptide (cdy) on tyro- 
sine residues. It has been clearly shown that tyrosine 
phosphorylation of Fc,RI p and y subunits is closely 
coupled with receptor engagement [l&23]. Although a 
number of tyrosine kinases have been demonstrated to be 
stimulated in response to Fc,RI signaling (lyn, WC, yes 131, 
and PTK 72”yk [5,7]), none of these kinases has been 
clearly shown to be the kinase which is responsible for 
antigen-mediated tyrosine phosphorylation of p and y 
subunits of Fc,RI. It has been shown by Quart0 and 
Metzger [25] that isolation of Fc,RI by affinity purification 
resulted in co-purification of an associated tyrosine kinase 
activity. Pribluda and Metzger [26] showed that this phos- 
phorylation of p and y subunits could occur in an anti- 
gen-mediated fashion in either sonicated cells, or isolated 
membranes, indicating that at least some of the kinases 
were constitutively associated with the membranes. Ben- 
hamou et al. [7] have shown that ~72”~~ is associated with 
Fc,RI only after antigen stimulation and is not constitu- 
tively associated. When we initially attempted to purify 
syk from stimulated RBL extracts, we observed a major 79 
kDa tyrosine phosphorylated band in the 0.65 M NaCl 
eluate of Heparin-agarose. Subsequent purification on 
IP: NRS Anti-Emb(A) (-) 
Y 
Y 
P 
P 
z 
97.4 
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43 
29 
Fig. 8. Anti Btk(A) Antibodies recognize the Btk gene product on B-cells 
and Btk-transfected NIH/3T3 cells. Lysates of 2 X 107 WEHI- cells, 
NIH/3T3 cells or a stable transfectant expressing Btk kinase were 
subjected to immunoprecipitation by normal rabbit serum or anti BtkfA) 
(designated in the figure as ‘anti-Emb(A)‘). The immunoprecipitates were 
subjected to in vitro kinase reaction for autophosphorylation and then 
analyzed on PAGE. The pure cdy kinase was autophosphorylated and 
run in parallel for comparison. Arrowhead at right shows expected 
position of Btk kinase. 
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Fig. 9. Phosphopeptide maps of the antigen precipitated in the experiment 
shown in Fig. 8. The 77 kDa bands from the gel in Fig. 8 were excised 
and digested by Staphylococcus aureus V8 protease by the standard 
Cleveland procedure [21]. The digested material was analyzed on PAGE 
and the dried gel was exposed for autoradiography (16 h exposure for the 
left two lanes and 4 days for the cdy kinase lane). Arrowhead shows 
position of the undigested kinasme. 
Mono Q and CM chromatographies revealed only the 79 
kDa protein band associated with the cdy kinase activity. 
The amount of purified cdy kinase recovered (approx. 200 
pg/109 cells) represented about 0.4% of the total cellular 
protein, assuming a 10% yield after the CM Sepharose 
step. As a comparison, type 1 CAMP dependent protein 
kinase is present as 0.44% of the cytoplasmic proteins in 
rabbit skeletal muscle [27] and it was also reported to be 
present in bovine heart at 0.81% of total cellular proteins 
[28]. Thus, the cdy kinase is present in significant amounts 
in RBL cells. Failure to precipitate by anti-syk antibodies, 
slightly different substrate specificity, and molecular weight 
on SDS-PAGE suggested that the purified cdy kinase was 
not syk. We tested to see: if the cdy kinase might be the 
Btk kinase, identified by PCR cloning of mouse bone 
marrow mast cells [14]. Western blotting by four different 
peptide-specific antibodies (two are shown in Fig. 61, as 
well as partial V8 proteinase mapping of the Btk kinase 
from different cell types, clearly suggests that our purified 
kinase is indeed identical with the Btk protein present in 
B-cells [lo] or in stable btk-transfected NIH/3T3 cells. 
The differences in reported molecular weight (77 kDa 
reported for the cloned enzyme vs. 79 kDa for our enzyme 
in the earlier experiments) could be easily explained by 
slight differences in molecular mass determination on 
SDS-PAGE. 
The Btk gene cloned from mast cells and B-cell Btk are 
99.3% identical. Moreover, the reagents used to identify 
cdy kinase as Btk are all well characterized for their 
antigen specificity and selectivity for cell types. In three of 
the four peptides used to raise the antibodies employed in 
this study, there is 100% identity in the sequence deduced 
from the B-cell and the mast cell genes. The fourth peptide 
has a single conserved amino acid difference (Ala to Val). 
All four antibodies immunoprecipitate as well as blot a 77 
kDa species (Btk) from normal or transformed mast cells, 
from WEHI- B-cell line and from NIH/3T3 cells 
transfected with the mouse Btk. These antibodies do not 
recognize any protein form T-cells, particularly not the 
Emt (Itk) protein which is the closest homologue identified 
thus far. They also do not recognize any protein at the 
> 50 kDa range from a non-transfected 3T3 cells or from 
vector-transfected cells. Furthermore, the anti N-terminal 
peptide recognize on blots the protein precipitated by the 
anti C-terminal peptide antibodies and vice versa (not 
shown). These features make these antibodies very rigor- 
ous tools for identification of the Btk gene product. 
As described by Tsukada et al. [lo], the Btk(BPK) 
kinase is present in B-cells at various stages of develop- 
ment, in myeloid cells, monocytic, and macrophage cell 
lines. The Btk kinase is not present in T-cells, or other 
non-lymphoid tissues. The kinase possesses a C-terminal 
catalytic domain, an adjacent SH-2 domain, and an SH-3 
domain upstream of the SH-2 domain. This is very similar 
to the domain structure found in the src family kinases. 
Btk contains a catalytic domain that includes an autophos- 
phorylation consensus similar to that found in pp60”‘” 
around Tyr-416. However, Btk lacks the glycine residue at 
position 2 which is utilized by pp60”‘” as a myristylation 
site [29]. Also lacking is a negative regulatory phospho- 
rylation site corresponding to Tyr-527 in ~~60”” [30]. 
Analysis of the catalytic domain of Btk reveals high 
homology to two other kinases, TEC, a liver specific PTK 
[31] and Dsrc28, a Drosophila PTK [32]. They showed 
55-61% identity vs. 40-45% identity for other src ki- 
nases. Btk is also highly homologous (approx. 50%) to a 
T-cell kinase referred to as Itk [lo]. In terms of function, 
we speculate from the relatively high K, of cdy kinase 
for cdy (approx. 0.2 mM) that the primary substrate for 
this enzyme may not be the y subunit of Fc,RI. Neverthe- 
less, no other enzyme with strong cdy kinase activity 
could be demonstrated in activated RBL’s in this study. 
Likewise, when cdy is in its native milieu, under the 
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effects of the adjacent membrane or of the state of aggre- 
gation, it might have a higher potential for phosphoryla- 
tion, thus exhibiting a lower K,. Such difference would 
arise from either conformational effects on the substrate or 
co-localization of the substrate closer to the activated 
kinase. Preliminary experiments failed to demonstrate the 
association of the Btk kinase to Fc,RI under a variety of 
conditions CT. Kawakami, unpublished results), unlike the 
syk kinase which associates with Fc,RI on triggering [7]. 
However, the receptor may serve as substrate for Btk even 
in the absence of a stable association, as SH2-mediated 
anchoring might not be a prerequisite for phosphorylation. 
It remains to be shown how and where Btk fits into the 
signal transduction pathway. The presence of SH-2 and 
SH-3 domains in the kinase make it likely that other 
tyrosine-phosphorylated proteins and cytoskeletal proteins 
might associate with the Btk kinase and result in its 
specific regulation and localization. Preliminary evidence 
indicates that Btk kinase is in fact activated by antigen 
stimulation of RBL cells [33]. This and the abundance of 
Btk found in RBL cells argues for its importance as a 
mediator of signal transduction in Fc,RI receptor trigger- 
ing of mast cells. 
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